What was once 25 treatments over five weeks can now often be delivered in 16 treatments, or even as few as five fractions.
Limited numeracy affects how patients interpret risk and treatment benefits, highlighting the need for clear, structured ...
FDA review uncertainty, failed phase 3 for ersodetug in HI, high-risk upLIFT trial, tight cash runway—read more macro ...
At the AD/PD 2026, Roche showcased new five-year data from the Phase II PASADENA trial (NCT03100149) involving prasinezumab.
Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...
The CDC and White House issued a health advisory about medetomidine, a deadly veterinary sedative known as rhino tranq, found ...
Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...
Cong Yimin, vice-president of PaiteBio, delivers a presentation on March 21 to the 2026 European Research Organization on Genital Infection and Neoplasia Congress held in Vienna, marking a new ...
Nektar Therapeutics (Nasdaq: NKTR) announced today that data from the ongoing Phase 2b studies of rezpegaldesleukin in ...
Grimaud Frères’ Yann Le Pottier explains how genetics, disease management and market awareness will shape the future ...
Sanford residents didn’t hold back as they grilled Aries officials over a proposed biosolids plant and the company’s past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results